MSI expresso: a software for determining MSI status and detecting MSI-related transcription events from RNA sequencing data
Year: 2025
Type: article
Abstract: Microsatellite instability (MSI) is becoming increasingly important in oncology as it has been reported across more than two dozen of solid cancer types. The MSI-high phenotype has long been used as a predictive and prognostic marker in colorectal cancer and has been recently approved by the FDA as a marker for immune checkpoint blockade therapy for solid cancers. Several bioinformatics tools have been developed to assess MSI status of a tumor sample using Next-Generation Sequencing (NGS) data mostly from whole genome, whole exome, and targeted gene sequencing data. While most tools available only infer the MSI status, none of them use RNA-sequencing (RNA-seq) data and provide per microsatellite expression and genotype results. We present MSI Expresso, a software which assesses the MSI status by testing the instability of a panel of 3'UTR microsatellites from RNA-seq data and also provides a detailed landscape of MSI-related events such as exon skipping, unstable coding and intronic microsatellites with a graphical output of the recurrent events. MSI Expresso's ability to detect the MSI status was assessed from RNA-seq data of 228 colon, 13 prostate and two endometrial cancer samples with known MSI status and achieved almost 100% concordant results. Thus, MSI Expresso is a new tool for MSI detection from RNA-sequencing data complementary to genomic and genetic approaches allowing to explore the consequence of MSI events on transcripts/transcriptome.
Source: Frontiers in Genetics
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
Funder: Agence Nationale de la Recherche
OpenAlex ID: W4409750633